Materialise NV ROE

ROE of MTLS for past 10 years: annual, quarterly and twelve month trailing (TTM) including ROE growth rates and interactive chart. ROE is expressed as a percentage and can be calculated for any company if net income and equity are both positive numbers. Net income is calculated before dividends paid to common shareholders and after dividends to preferred shareholders and interest to lenders. A company with average equity of $10 million and earnings of $2 milion will have a ROE of 20%.


Highlights and Quick Summary

  • Annual ROE for 2020 was -5.08% (a -545.61% decrease from previous year)
  • Annual ROE for 2019 was 1.14% (a -60.42% decrease from previous year)
  • Annual ROE for 2018 was 2.88% (a -205.88% decrease from previous year)
  • Twelve month ROE ending September 29, 2021 was 3.55% (a -320.5% decrease compared to previous quarter)
  • Twelve month trailing ROE decreased by -170.86% year-over-year
Trailing ROE for the last four month:
29 Sep '21 29 Jun '21 30 Mar '21 30 Dec '20
3.55% -1.61% -6.24% -5.01%
Visit stockrow.com/MTLS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical ROE of Materialise NV

Most recent ROEof MTLS including historical data for past 10 years.

Interactive Chart of ROE of Materialise NV

Materialise NV ROE for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 -5.08%
2019 1.14%
2018 2.88%
2017 -2.72%
2016 -3.81%
2015 -3.04%
2014 0.0%
2013 0.0%

Business Profile of Materialise NV

Sector: Technology
Industry: Software—Application
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. It operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.